SkinBioTherapeutics Plc (SBTX.L) LSE

15.00

+0.25(+1.69%)

Updated at September 08 02:34PM

Currency In GBp

Valuation

Market Cap16.77M
Enterprise Value16.78M
P/E Ratio-12.57
PEG Ratio-0.67
Price/Sales Ratio14.02
Price/Book Ratio7.21
Enterprise/Revenue13.94
Enterprise/EBITDA-16.4

Fiscal Year

Fiscal YearJune 30, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.96
Operating Margin-0.95

Management Effectiveness

Return On Assets-0.35
Return On Equity-0.69

Income Statement

Revenue1.21M
Revenue/Share0.01
Gross Profit683,038
EBITDA-2.72M
Net Income-2.88M
Diluted EPS-0.02

Balance Sheet

Total Cash1.24M
Total Cash/Share0.01
Total Debt1.03M
Total Debt/Equity0.23
Current Ratio1.79
Book Value Per Share0.02

Price History

52-Week Change22.18
52-Week High27.5
52-Week Low9
Moving Average 50 Days15.78
Moving Average 200 Days18.53

Statistics

Average Volume1.27M
Shares Outstanding258.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A